Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    23281974 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Treatment of Chronic Hepatitis With Sofosbuvir in Combination With Ribavirin With or Without Pegylated Interferon: North India Gastroenterology Consortium
Condition: Hepatitis, Chronic
Intervention: Drug: Sofosbuvir, Ribavirin, With or Without Pegylated Interferon
2 Recruiting Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Condition: Liver Disease
Interventions: Drug: sofosbuvir/ledipasvir;   Drug: sofosbuvir;   Drug: Ribavirin
3 Terminated Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)
Condition: Hepatitis C Viral Infection
Intervention: Drug: Sofosbuvir (SOF) and Ledipasvir (LDV)
4 Completed
Has Results
Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3
Condition: Chronic Hepatitis C Infection
Interventions: Drug: SOF;   Drug: RBV;   Drug: PEG;   Drug: LDV;   Drug: GS-9669;   Drug: LDV/SOF

Indicates status has not been verified in more than two years